Reversible Carnitine Palmitoyltransferase Inhibitors with Broad Chemical Diversity as Potential Antidiabetic Agents
作者:Fabio Giannessi、Piero Chiodi、Mauro Marzi、Patrizia Minetti、Pompeo Pessotto、Francesco De Angelis、Emanuela Tassoni、Roberto Conti、Fabrizio Giorgi、Massimo Mabilia、Natalina Dell'Uomo、Sandra Muck、Maria O. Tinti、Paolo Carminati、Arduino Arduini
DOI:10.1021/jm010889+
日期:2001.7.1
A series of carnitine related compounds of general formula XCH(2)CHZRCH(2)Y were evaluated as CPT I inhibitors in intact rat liver (L-CPT I) and heart mitochondria (M-CPT I). Derivative 27 (ZR = -HNSO(2)R, R = C(12), X = trimethylammonium, Y = carboxylate, (R) form) showed the highest activity (IC(50) = 0.7 microM) along with a good selectivity (M-CPT I/L-CPTI IC(50) ratio = 4.86). Diabetic db/db mice
评估了一系列通式XCH(2)CHZRCH(2)Y与肉碱相关的化合物作为完整大鼠肝脏(L-CPT I)和线粒体(M-CPT I)中的CPT I抑制剂。衍生物27(ZR = -HNSO(2)R,R = C(12),X =三甲基铵,Y =羧酸盐,(R)形式)表现出最高的活性(IC(50)= 0.7 microM)以及良好的选择性(M-CPT I / L-CPTI IC(50)比率= 4.86)。口服27颗糖尿病db / db小鼠显示血清葡萄糖水平显着降低。